Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) was $8.50 for the day, up 1.80% from the previous closing price of $8.35. In other words, the price has increased by $1.80 from its previous closing price. On the day, 1.0 million shares were traded. MRVI stock price reached its highest trading level at $8.52 during the session, while it also had its lowest trading level at $8.165.
Ratios:
Our analysis of MRVI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.28 and its Current Ratio is at 10.00. In the meantime, Its Debt-to-Equity ratio is 1.29 whereas as Long-Term Debt/Eq ratio is at 1.26.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Overweight rating and assigned the stock a target price of $10.
On August 13, 2024, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also lowered its target price recommendation from $11 to $10.
On April 10, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $15.Craig Hallum initiated its Buy rating on April 10, 2024, with a $15 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 28 ’24 when GTCR INVESTMENT XI LLC sold 9,940,974 shares for $9.81 per share. The transaction valued at 97,570,660 led to the insider holds 20,150,005 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 2144014464 and an Enterprise Value of 1556910336. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.32 while its Price-to-Book (P/B) ratio in mrq is 2.75. Its current Enterprise Value per Revenue stands at 5.589 whereas that against EBITDA is 753.222.
Stock Price History:
Over the past 52 weeks, MRVI has reached a high of $11.56, while it has fallen to a 52-week low of $4.52. The 50-Day Moving Average of the stock is -0.27%, while the 200-Day Moving Average is calculated to be 5.55%.
Shares Statistics:
MRVI traded an average of 1.94M shares per day over the past three months and 1090780 shares per day over the past ten days. A total of 132.23M shares are outstanding, with a floating share count of 116.75M. Insiders hold about 16.98% of the company’s shares, while institutions hold 90.02% stake in the company. Shares short for MRVI as of 1727654400 were 9219389 with a Short Ratio of 4.75, compared to 1724976000 on 8375611. Therefore, it implies a Short% of Shares Outstanding of 9219389 and a Short% of Float of 7.7700000000000005.
